Transcriptome analysis of bovine macrophages (BoMac) cells after infection with bovine immunodeficiency virus
, , , , oraz
26 gru 2022
O artykule
Data publikacji: 26 gru 2022
Zakres stron: 487 - 495
Otrzymano: 28 wrz 2022
Przyjęty: 13 gru 2022
DOI: https://doi.org/10.2478/jvetres-2022-0072
Słowa kluczowe
© 2022 M. Rola-Łuszczak et al. published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1

Fig. 2

Fig. 3

Disease and biofunctions identified by IPA ordered with respect to activation z-score
Diseases or functions annotation | P-value | Activation z-score | Number of molecules |
---|---|---|---|
Inflammation of joints | 4.61E−09 | −3.228* | 143 |
Inflammatory response | 1.71E−06 | −2.003* | 103 |
Activation of leukocytes | 6.71E−07 | −1.664 | 88 |
Inflammation of respiratory system component | 6.93E−06 | −1.518 | 76 |
Inflammation of body cavity | 4.07E−06 | −1.467 | 139 |
Rheumatoid arthritis | 2.18E−07 | −1.387 | 102 |
Inflammation of lungs | 3.60E−06 | −1.379 | 54 |
Allergic pulmonary eosinophilia | 2.95E−06 | −1.342 | 12 |
Inflammation of organs | 1.03E−07 | −1.088 | 187 |
Inflammation of absolute anatomical region | 6.76E−06 | −1.049 | 153 |
Immune response of tumour cell lines | 1.06E−05 | −0,788 | 29 |
Dermatitis | 9.31E−06 | −0.363 | 68 |
Primers and TaqMan probes used in this study for BIV and GAPDH gene amplification
Primer/Probe | Sequence 5′ → 3′ | Position in target sequence | Product length (bp) | Application |
---|---|---|---|---|
BIVg723F | GAAGCAGACATCGAATCAGA | 723–742a | 552 | BIV standard |
BIVg1274R | TCTTTTGTGGTTTCTGGAGC | 1255–1274 a | DNA | |
BTG1F | TGATGCTGGTGCTGAGTATGTG | 4–25b | 182 | |
BTG2R | CCTTCAAGTGAGCCTGCAGCAA | 164–185 b | DNA | |
BIVg1074F | ACAAGCCACCCTGATCTCAGTA | 1074–1095 a | 128 | RT-qPCR and |
BIVg1202R | TCCTTGGGTTCCCTGATGAATGT | 1181–1202 a | qPCR- | |
BIVg1107P | Cy5 - AACTTTCAGACAGTGGGTGCTGCAGG - BHQ3 | 1107–1132 a | - | BIV |
BTG3F | CCACTGGGGTCTTCACTACCAT | 33–54 b | ||
BTG4R | AAGTTAATTGCACCCGGGCTCT | 137–158 b | 126 | |
BTG5P | JOE - CTGGAGAGGAGGGTGTAACAGGA - BHQ1 | 83–105 b | - |
The top-scoring regulatory networks identified using IPA software
Consistency score | Node total | Regulator total | Regulators | Target total | Target molecules in dataset | Diseases & functions |
---|---|---|---|---|---|---|
1.291 |
20 |
4 |
ELF4, INSIG1, INSR, mir-148 |
15 |
Inflammation of joints |
|
−7.211 |
15 |
1 |
INSR |
13 |
Inflammatory response |
|
−7.500 |
6 |
1 |
RABGEF1 |
4 |
Metabolism of protein |
|
−7.506 |
5 |
1 |
ALDH1A2 |
3 |
Neonatal death |
|
−8.660 | 5 | 1 | DDX3X | 3 | Metabolism of protein |
Comparison of gene expression changes observed in microarray analysis and RT-qPCR
Gene | Reference sequence ID | Primer sequence (5′–3′) | FC | |
---|---|---|---|---|
Microarray | RT-qPCR | |||
174481* NM_ | F: ACAAAGACAACTTGCTGAGGAACCC | N/A | N/A | |
R: GGCAACCTCTGACTGAATAGCACTT | ||||
XM_002685057.2 | F: AATGCACGTGTCCTTCGATA | 2.45 | 1.05 | |
R: TGAAAAGGCCAAGACTCATGT | ||||
NM_001013401.2 | F: CCCTCAGAGCCTCGCTTT | 2.00 | 1.19 | |
R: GCGAGACATCAGAAGAAAGAGC | ||||
NM_001562 | F: AGACAGGTTGATTTCCCTGGT | −1.50 | −1.15 | |
R: CCTGGAATCAGATCACTTTGG | ||||
XM_024982390 | F: GCGACCAGAGGGGGAACTC | −1.50 | −1.03 | |
R: TAGCACTGGCAGCGAAAGTGCA | ||||
F: TGGTGGAGACTGCCTGCG | ||||
XM_024986251 | R: CCGACTAAAGAGGTTCTAGCAC | 3.00 | 1.12 |